Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
19.48
+0.72 (3.84%)
At close: Jun 27, 2025, 4:00 PM
19.10
-0.38 (-1.95%)
After-hours: Jun 27, 2025, 5:08 PM EDT
Rigel Pharmaceuticals Employees
As of December 31, 2024, Rigel Pharmaceuticals had 164 total employees, including 162 full-time and 2 part-time employees. The number of employees increased by 17 or 11.56% compared to the previous year.
Employees
164
Change (1Y)
17
Growth (1Y)
11.56%
Revenue / Employee
$1,238,274
Profits / Employee
$226,695
Market Cap
348.15M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RIGL News
- 4 weeks ago - Rigel to Present at the Jefferies Global Healthcare Conference - PRNewsWire
- 5 weeks ago - Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PRNewsWire
- 7 weeks ago - Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum - Seeking Alpha
- 7 weeks ago - Rigel Pharmaceuticals, Inc. (RIGL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 2 months ago - Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update - PRNewsWire
- 3 months ago - Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability - Seeking Alpha
- 3 months ago - Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire